Baxter Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Baxter Pharmaceuticals's estimated annual revenue is currently $148.9M per year.
- Baxter Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Baxter Pharmaceuticals has 741 Employees.
- Baxter Pharmaceuticals grew their employee count by 5% last year.
Baxter Pharmaceuticals's People
Name | Title | Email/Phone |
---|
Baxter Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $145.5M | 517 | 0% | $28.5M | N/A |
#2 | $102.7M | 511 | 7% | N/A | N/A |
#3 | $58.7M | 292 | 1% | N/A | N/A |
#4 | $8.2M | 41 | -2% | N/A | N/A |
#5 | $22.5M | 112 | 12% | $23.6M | N/A |
#6 | $5.6M | 28 | 4% | N/A | N/A |
#7 | $11.3M | 56 | 8% | N/A | N/A |
#8 | $13.1M | 65 | 7% | N/A | N/A |
#9 | $7.6M | 38 | 15% | N/A | N/A |
#10 | $7.2M | 36 | 3% | N/A | N/A |
What Is Baxter Pharmaceuticals?
Baxter Pharmaceuticals is a pharmaceuticals company based out of 4750 Pleasant Hill Rd, Memphis, Tennessee, United States.
keywords:N/AN/A
Total Funding
741
Number of Employees
$148.9M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Baxter Pharmaceuticals News
2022-04-20 - Alpha Antitrypsin Market Size, Outlook And Forecast | Grifols ...
Grifols, S.A., Baxter International Inc., Kamada Ltd., Grifols Therapeutics, Inc. (Inactive), CSL Limited, Arriva Pharmaceuticals, Bayer AG.
2022-04-20 - Targeted Drug Delivery Market is Projected to Grow at a 15.9 ...
AbbVie Inc., Ablynx NV by Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca PLC, Boston Scientific Corporation,...
2022-04-19 - Atrial Fibrillation Drugs Market Size, Scope And Forecast ...
ARCA Biopharma, Baxter International Inc., Bristol-Myers Squibb, Gilead Sciences, HUYA Biosciences, Janssen Pharmaceuticals, Pfizer Inc.,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1590M | 812 | 8% | N/A |
#2 | $376.1M | 819 | 8% | N/A |
#3 | $393.2M | 851 | 6% | N/A |
#4 | $409.1M | 891 | -2% | N/A |
#5 | $249.5M | 990 | N/A | N/A |